CVS Health Corporation (NYSE:CVS) Q3 2024 Earnings Conference Call November 6, 2024 8:00 AM ET Company Participants David Joyner - President, Chief Executive Officer Tom Cowhey - Executive Vice President, Chief Financial Officer Prem Shah - Group President Larry McGrath - Chief Strategy Officer, Investor Relations Conference Call Participants Lisa Gill - JP Morgan Justin Lake - Wolfe Research Stephen Baxter - Wells Fargo Michael Cherny - Leerink Partners Josh Raskin - Nephron Research Elizabeth Anderson - ...

Key TakeawaysCVS Health reported better-than-expected quarterly results, and the new CEO made executive changes. The news lifted the stock Wednesday. Revenue was lifted by jumps in sales at the firm's Pharmacy & Wellness and Health Care Benefits segments.CVS also shook up its executive lineup, adding former UnitedHealth Group executive Steve Nelson to run the Aetna insurance division. CVS Health (CVS) shares surged after the pharmacy chain and healthcare company posted better-than-expected results and new C ...

OCEANSIDE, NEW YORK - AUGUST 23: A general view of a CVS Pharmacy store on August 23, 2024 in ... [+] Oceanside, New York. Long Island is the home for a plethora of local and national business concerns. (Photo by Bruce Bennett/Getty Images)Getty ImagesCVS Health stock (NYSE: CVS) is up over 10% on Wednesday, November 6. The broader markets as well as the health insurance stocks are rallying after the Trump victory. Other than CVS, UnitedHealth stock (NYSE:UNH) is up 5%, and Humana stock is up 8%. Now, CVS a ...

CVS Health Corp (NYSE:CVS) stock is 12% higher at $61.96 at last glance, after the pharmacy giant reported a mixed third quarter. Higher medical costs impacted net income, with adjusted earnings of $1.09 per share falling short of the $1.44 per share consensus estimate, but revenue of $95.43 billion was well above the $92.72 billion forecast. This was the company's first earnings report with newly appointed CEO David Joyner.In addition to the top- and bottom-line results, CVS Health cut its full-year profit ...

For the quarter ended September 2024, CVS Health (CVS) reported revenue of $95.43 billion, up 6.3% over the same period last year. EPS came in at $1.09, compared to $2.21 in the year-ago quarter.The reported revenue represents a surprise of +2.75% over the Zacks Consensus Estimate of $92.87 billion. With the consensus EPS estimate being $1.07, the EPS surprise was +1.87%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street ex ...

CVS Health (CVS) came out with quarterly earnings of $1.09 per share, beating the Zacks Consensus Estimate of $1.07 per share. This compares to earnings of $2.21 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 1.87%. A quarter ago, it was expected that this drugstore chain and pharmacy benefits manager would post earnings of $1.74 per share when it actually produced earnings of $1.83, delivering a surprise of 5.17%.Over the la ...

About this content About Oliver Haill Oliver has been writing about companies and markets since the early 2000s, cutting his teeth as a financial journalist at Growth Company Investor with a focusing on AIM companies and small caps, before a few years later becoming a section editor and then head of research. He joined Proactive after a couple of years freelancing, where he worked for the Financial Times Group, ITV, Press Association, Reuters sports desk, the London Olympic News Service, Rugby World Cup ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to_________ Commission File Number: 001-01011 ♥CVSHealth CVS HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 17, 2024 CVS HEALTH CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-01011 05-0494040 (State or Other Jurisdiction of Incorporation)(Commission File Number)(I.R.S. Employer Identification No.) One CVS Drive Woonsocket, Rhode Island 02895 (Address of Principal Ex ...

CVS Health on Wednesday reported mixed third-quarter results as higher medical costs squeezed its bottom line. The earnings report is CEO David Joyner's first at the helm of the troubled retail drugstore chain. The company expects elevated medical costs to continue to pressure its performance this year, "and as a result we are not providing a formal outlook at this time," a spokesperson told CNBC. CVS will provide commentary on what it expects "directionally" during its earnings call, the spokesperson said. ...